Market Overview

Morning Market Losers

Related ATHX
Events for the Week of Oct. 13-17, 2014
Athersys Reports Wider-than-Expected Q1 Loss - Analyst Blog
Related OGXI
OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer
Stocks Hitting 52-Week Lows

Athersys (NASDAQ: ATHX) shares tumbled 55.99% to $1.20 on failed trial results for ulcerative colitis.

OncoGenex Pharmaceuticals (NASDAQ: OGXI) dipped 53.61% to $4.50 after the company and Teva Pharmaceutical Industries (NYSE: TEVA) offered top-line survival results of the Phase III SYNERGY trial for combo with first-line docetaxel/prednisone therapy.

Eltek (NASDAQ: ELTK) declined 19.87% to $1.73 after the company reported Q4 earnings of $0.39 per share on revenue of $12.70 million.

POZEN (NASDAQ: POZN) declined 15.66% to $7.70 following Friday's Complete Response Letter from the FDA.

New Oriental Education & Technology Group (NYSE: EDU) shares dropped 11.35% to $23.03 after the company reported FQ3 results. New Oriental's quarterly net income surged 50.2% y/y to US$42.1 million versus US$28.0 million.

Sohu.com (NASDAQ: SOHU) fell 7.91% to $53.41 after the company reported a Q1 adjusted loss of $1.26 per share on revenue of $365.0 million.

Newmont Mining (NYSE: NEM) shares slipped 6.01% to $24.86 after the company terminated its merger talks with Barrick Gold (NYSE: ABX).

Bank of America (NYSE: BAC) shares slipped 4.83% to $15.18 following news from the company the Board will be suspending the previously announced capital actions and resubmit the 2014 capital plan.

Mylan (NASDAQ: MYL) tumbled 4.15% to $49.94 after Meda's board rejected Mylan proposal.

Changyou.com (NASDAQ: CYOU) shares slipped 3.94% to $25.60 after the company reported a Q1 loss $0.37 per share on revenue of $180.80 million.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets

 

Related Articles (ATHX + ABX)

Around the Web, We're Loving...

Get Benzinga's Newsletters